A Prostate Researcher Tested Firm's Product -- and Sat on its Board

Number 14642
Subject Health Care
Source Wall Street Journal (New York)
Year 1998
Publication Date March 19, 1998
Summary Joseph Oesterling, former professor and chief of urology at the University of Michigan Medical Center, was a leading proponent of a surgical procedure for enlarged prostates. He was the main investigator in clinical trials of the procedure. However, he was also a member of the board of directors of the company whose procedure and special surgical equipment he was testing. The company (ViaMed Inc.) gave him options to acquire 13,334 shares of its stock and paid for him to attend conferences around the world. It isn't unusual for influential medical professors to receive honorariums, consulting fees and expense-paid travel from medical companies whose products they write about or even test.
Category General
Related Links
Related Video
Ordering info Want to place an order? Email us or call us at 573-882-3364 (Stories are only available to members of IRE. For membership information, please refer to our membership page)